- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- S-1/A IPO registration
- 3.1 Exhibit 3.1
- 3.2 Exhibit 3.2
- 4.1 Exhibit 4.1
- 4.2 Exhibit 4.2
- 4.3 Exhibit 4.3
- 4.4 Exhibit 4.4
- 4.5 Exhibit 4.5
- 4.6 Exhibit 4.6
- 4.7 Exhibit 4.7
- 4.8 Exhibit 4.8
- 4.9 Exhibit 4.9
- 10.1 Exhibit 10.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.4 Exhibit 10.4
- 10.5 Exhibit 10.5
- 10.6 Exhibit 10.6
- 10.7 Exhibit 10.7
- 10.8 Exhibit 10.8
- 10.9 Exhibit 10.9
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11
- 10.12 Exhibit 10.12
- 10.13 Exhibit 10.13
- 10.14 Exhibit 10.14
- 10.15 Exhibit 10.15
- 10.16 Exhibit 10.16
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 14.1 Exhibit 14.1
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 99.1 Exhibit 99.1
- 99.2 Exhibit 99.2
- 99.3 Exhibit 99.3
- 99.4 Exhibit 99.4
- 99.5 Exhibit 99.5
- EX-FILING FEES Ex-filing Fees
- 30 Aug 23 424B4 Prospectus supplement with pricing info
- 30 Aug 23 EFFECT Notice of effectiveness
- 23 Aug 23 S-1/A IPO registration (amended)
- 17 Aug 23 S-1/A IPO registration (amended)
- 8 Aug 23 S-1/A IPO registration (amended)
- 4 Aug 23 FWP Free writing prospectus
- 4 Aug 23 S-1/A IPO registration (amended)
- 2 Aug 23 S-1/A IPO registration (amended)
- 27 Jul 23 FWP Free writing prospectus
- 14 Jul 23 S-1/A IPO registration (amended)
- 16 Jun 23 S-1/A IPO registration (amended)
-
23 May 23 S-1/A IPO registration (amended)
- 25 Apr 23 S-1/A IPO registration (amended)
- 10 Apr 23 S-1 IPO registration
Exhibit 99.1
CONSENT TO BE NAMED AS DIRECTOR
In connection with the Registration Statement on Form S-1 (including any and all amendments, including post-effective amendments, or supplements thereto, the “Registration Statement”) of Inspire Veterinary Partners, Inc. (the “Company”), the undersigned hereby consents to being named and described in the Registration Statement filed with the U.S. Securities and Exchange Commission as a person to become a director of the Company, with such appointment to become effective upon the listing of the Company’s Class A common stock on the Nasdaq Capital Market, and to the filing or attachment of this Consent with such Registration Statement.
IN WITNESS WHEREOF, the undersigned has executed this Consent as of the 24th day of April, 2023.
By: | /s/ Anne Murphy | |
Anne Murphy |